Licensable Technology

Inventor Reiser

• Dynamin Mutants for Drug-Screening Assays and Gene Therapy of Proteinuric Kidney Disease
  IP Type: Licensable Technology
  Organization: Massachusetts General Hospital
  Tech Type: Therapeutics - Methods | Therapeutics - Drugs
  http://www.masstechportal.org
  
  
• Interference with AlphaVBeta3 Integrin for the Treatment of Proteinuric Kidney Diseases
  IP Type: Licensable Technology
  Organization: Massachusetts General Hospital
  Tech Type: Therapeutics - Methods | Therapeutics - Drugs
  
  
• Proteolytic cleavage of CD2AP regulating podocyte survival
  IP Type: Licensable Technology
  Organization: University of Miami
  Tech Type: Therapeutics - Methods | Therapeutics - Drugs
  
  
• Role of soluble urokinase receptor as a circulating glomerular disease factor
  IP Type: Licensable Technology
  Organization:   University of Miami
  Tech Type: Therapeutics - Methods | Therapeutics Drugs